Mass spectrometry (MS)-based omics technologies are now widely used to profile small
molecules in multiple matrices to confer comprehensive snapshots of cellular metabolic …

Nonalcoholic fatty liver disease (NAFLD), or, more accurately, metabolic associated fatty
liver disease, accounts for a large proportion of chronic liver disorders worldwide and is …

Background Non-invasive tests that can identify patients with non-alcoholic steatohepatitis
(NASH) at higher risk of disease progression are lacking. We report the development and …

In recent years, researchers have become focused on the relationship between lipids and
bone metabolism balance. Moreover, many diseases related to lipid metabolism disorders …

Abstract Background and Aims The mechanisms governing the progression of non‐
alcoholic fatty liver disease (NAFLD) towards steatohepatitis (NASH) and hepatocellular …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as Non-
Alcoholic Fatty Liver Disease, is a widespread liver condition characterized by excessive fat …

Gluconeogenesis is a critical biosynthetic process that helps maintain whole-body glucose
homeostasis and becomes altered in certain medical diseases. We review gluconeogenic …

Considering high prevalence of non-alcoholic fatty liver diseases (NAFLD) in patients with
inflammatory bowel disease (IBD), this study aimed to elucidate molecular mechanisms for …

Glucose is a 6-carbon structure with the chemical formula C 6 H 12 O 6. Carbohydrates are
ubiquitous energy sources for every organism worldwide and are essential to fuel aerobic …

The past decade has seen many advancements in the development of three-dimensional
(3D) in vitro models in pharmaceutical sciences and industry. Specifically, organoids present …